A search and verification of downstream targets revealed that RUNX1 plays a major role in the malignant progression of Mes GBM, affecting the formation of extracellular matrix through MGP and promoting the ability of tumor cells (especially cancer stem cells) to invade into normal tissues. Here, MGP is linked to glioblastoma.